Applied BioCode Corporation (TPE:6598)
23.35
-0.20 (-0.85%)
At close: Mar 27, 2026
Applied BioCode Balance Sheet
Financials in millions TWD. Fiscal year is January - December.
Millions TWD. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Equivalents | 464.79 | 605.96 | 413.19 | 831.32 | 646.07 |
Short-Term Investments | 104.8 | 251.53 | 191.62 | - | - |
Cash & Short-Term Investments | 569.59 | 857.49 | 604.82 | 831.32 | 646.07 |
Cash Growth | -33.58% | 41.78% | -27.25% | 28.67% | -23.80% |
Receivables | 121.98 | 45.02 | 51.04 | 70.81 | 67.81 |
Inventory | 156.29 | 190.07 | 174.97 | 106.68 | 101.37 |
Other Current Assets | 10.6 | 11.71 | 6.53 | 5.48 | 11.2 |
Total Current Assets | 858.46 | 1,104 | 837.36 | 1,014 | 826.45 |
Property, Plant & Equipment | 144.53 | 98.79 | 131.14 | 169.62 | 162.77 |
Other Intangible Assets | 0.09 | 1.8 | 6.02 | 10.38 | 13.43 |
Long-Term Deferred Tax Assets | 2.98 | 3.11 | 4.5 | 3.99 | 3.51 |
Other Long-Term Assets | 6.65 | 6.92 | 14.19 | 14.18 | 12.8 |
Total Assets | 1,013 | 1,215 | 993.21 | 1,212 | 1,019 |
Accounts Payable | 15.68 | 6.44 | 2.58 | 8.73 | 9.43 |
Accrued Expenses | - | 35.63 | 32.08 | 35.06 | 26.11 |
Current Portion of Leases | 20.79 | 17.26 | 16.35 | 15.66 | 14.2 |
Current Income Taxes Payable | - | 2.53 | 0.47 | 1.5 | 4.18 |
Current Unearned Revenue | 42.78 | 54.59 | 43.25 | 22.77 | 1.99 |
Other Current Liabilities | 47.29 | 13.38 | 6.84 | 3.91 | 4.05 |
Total Current Liabilities | 126.55 | 129.83 | 101.56 | 87.63 | 59.95 |
Long-Term Leases | 38.77 | 2.27 | 18.08 | 33.45 | 44.56 |
Long-Term Unearned Revenue | 201.2 | 200.87 | 208.08 | 271.33 | 7.99 |
Long-Term Deferred Tax Liabilities | 2.98 | 3.11 | 4.5 | 3.99 | 3.51 |
Total Liabilities | 369.49 | 336.07 | 332.22 | 396.38 | 116.01 |
Common Stock | 1,028 | 1,028 | 817.68 | 817.63 | 817.29 |
Additional Paid-In Capital | 37.22 | 272.28 | 43.81 | 359.24 | 351.58 |
Retained Earnings | -417.81 | -453.97 | -193.16 | -349.93 | -165.2 |
Comprehensive Income & Other | -4.31 | 32.65 | -7.34 | -10.88 | -100.71 |
Shareholders' Equity | 643.22 | 878.83 | 660.99 | 816.07 | 902.96 |
Total Liabilities & Equity | 1,013 | 1,215 | 993.21 | 1,212 | 1,019 |
Total Debt | 59.56 | 19.52 | 34.43 | 49.11 | 58.76 |
Net Cash (Debt) | 510.03 | 837.96 | 570.39 | 782.21 | 587.31 |
Net Cash Growth | -39.13% | 46.91% | -27.08% | 33.18% | -25.32% |
Net Cash Per Share | 4.97 | 9.25 | 6.98 | 9.57 | 7.19 |
Filing Date Shares Outstanding | 102.81 | 102.79 | 81.77 | 81.76 | 81.73 |
Total Common Shares Outstanding | 102.81 | 102.79 | 81.77 | 81.76 | 81.73 |
Working Capital | 731.92 | 974.46 | 735.8 | 926.66 | 766.5 |
Book Value Per Share | 6.26 | 8.55 | 8.08 | 9.98 | 11.05 |
Tangible Book Value | 643.13 | 877.03 | 654.97 | 805.69 | 889.52 |
Tangible Book Value Per Share | 6.26 | 8.53 | 8.01 | 9.85 | 10.88 |
Machinery | - | 78.54 | 70.92 | 67.91 | 91.96 |
Construction In Progress | - | - | 1.4 | 17.9 | 1.01 |
Leasehold Improvements | - | 75.3 | 70.79 | 52.29 | 46.71 |
Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.